We have located links that may give you full text access.
A Pr 3+ doping strategy for simultaneously optimizing the size and near infrared persistent luminescence of ZGGO:Cr 3+ nanoparticles for potential bio-imaging.
Physical Chemistry Chemical Physics : PCCP 2017 September 21
Spinel-phase Zn2 Ga2.98-x Ge0.75 O8 :Cr0.020 ,Prx (ZGGO:Cr3+ ,Pr3+ ) near infrared (NIR) persistent luminescence nanoparticles (PLNPs) with different amounts of Pr3+ dopant were prepared by a hydrothermal method in combination with a subsequent annealing in a vacuum. For these nanoparticles, the averaged particle size decreases from 64 to 37 nm with increasing Pr3+ doping concentration from 0 to 0.025 and Cr3+ and Pr3+ ions are uniformly doped into the interior and surface of a single nanoparticle. It can be found that Pr3+ doping leads to the appearance of more anti-site pairs () around distorted octahedral Cr3+ ions and enhanced NIR emissions around 697 nm, which originate from the2 E(2 G) →4 A2 (4 F) and4 T2 (4 F) →4 A2 (4 F) transitions of the interior and surface Cr3+ ions in the nanoparticles. In particular, for the interior Cr3+ ions in the Pr3+ doped nanoparticles, the enhanced NIR luminescence can be attributed to the suppressed energy transfer of the excited electrons from the4 T2 (4 F) level to the trap level related to anti-site pairs () around the distorted octahedral Cr3+ ions. Our results suggest that Pr3+ doped ZGGO:Cr3+ PLNPs have potential applications for bio-imaging.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app